H2B1C_HUMAN - dbPTM
H2B1C_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H2B1C_HUMAN
UniProt AC P62807
Protein Name Histone H2B type 1-C/E/F/G/I
Gene Name HIST1H2BC
Organism Homo sapiens (Human).
Sequence Length 126
Subcellular Localization Nucleus. Chromosome.
Protein Description Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; Has broad antibacterial activity. May contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid..
Protein Sequence MPEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MPEPAKSAP
------CCCCCCCCC
57.17-
5Phosphorylation---MPEPAKSAPAPK
---CCCCCCCCCCCC
19.44-
6N6-crotonyl-L-lysine--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.84-
6Acetylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8419608861
6Butyrylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8427105113
6Crotonylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8421925322
6Lactoylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8431645732
6Methylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8416283522
6Other--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8427105115
6Sumoylation--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8419608861
6Ubiquitination--MPEPAKSAPAPKK
--CCCCCCCCCCCCC
58.8423000965
7Phosphorylation-MPEPAKSAPAPKKG
-CCCCCCCCCCCCCC
41.4123401153
12N6-crotonyl-L-lysineAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.39-
12AcetylationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3916627869
12CrotonylationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3921925322
12LactoylationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3931645732
12OtherAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3927105115
12UbiquitinationAKSAPAPKKGSKKAV
CCCCCCCCCCCHHHH
72.3923000965
13N6-crotonyl-L-lysineKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.32-
13AcetylationKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.3216283522
13CrotonylationKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.3221925322
13OtherKSAPAPKKGSKKAVT
CCCCCCCCCCHHHHH
68.3224681537
15PhosphorylationAPAPKKGSKKAVTKA
CCCCCCCCHHHHHHH
39.601137958
16N6-crotonyl-L-lysinePAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.11-
16AcetylationPAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.1116283522
16CrotonylationPAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.1121925322
16LactoylationPAPKKGSKKAVTKAQ
CCCCCCCHHHHHHHH
54.1131645732
17N6-crotonyl-L-lysineAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.19-
17AcetylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1916627869
17CrotonylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1921925322
17GlutarylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1931542297
17LactoylationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1931645732
17OtherAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1927105115
17UbiquitinationAPKKGSKKAVTKAQK
CCCCCCHHHHHHHHH
50.1925015289
21N6-crotonyl-L-lysineGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.07-
21AcetylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0716283522
21ButyrylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0727105113
21CrotonylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0721925322
21LactoylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0731645732
21OtherGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0727105115
21SumoylationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0716283522
21UbiquitinationGSKKAVTKAQKKDGK
CCHHHHHHHHHHCCC
42.0725015289
24N6-crotonyl-L-lysineKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.66-
24AcetylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.66158385
24CrotonylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6621925322
24LactoylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6631645732
24MethylationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.66-
24OtherKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6624681537
24UbiquitinationKAVTKAQKKDGKKRK
HHHHHHHHHCCCCCC
58.6625015289
25AcetylationAVTKAQKKDGKKRKR
HHHHHHHHCCCCCCC
60.68158509
25OtherAVTKAQKKDGKKRKR
HHHHHHHHCCCCCCC
60.6824681537
29UbiquitinationAQKKDGKKRKRSRKE
HHHHCCCCCCCCCHH
69.5423000965
30UbiquitinationQKKDGKKRKRSRKES
HHHCCCCCCCCCHHH
43.0123000965
31UbiquitinationKKDGKKRKRSRKESY
HHCCCCCCCCCHHHH
64.7023000965
33PhosphorylationDGKKRKRSRKESYSV
CCCCCCCCCHHHHHH
51.2228152594
35N6-crotonyl-L-lysineKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.86-
35AcetylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8622389435
35CrotonylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8621925322
35GlutarylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8631542297
35MalonylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8626320211
35OtherKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8627105115
35SuccinylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8622389435
35UbiquitinationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8623000965
36UbiquitinationKRKRSRKESYSVYVY
CCCCCCHHHHHHHHH
54.5223000965
37PhosphorylationRKRSRKESYSVYVYK
CCCCCHHHHHHHHHH
26.2425159151
38PhosphorylationKRSRKESYSVYVYKV
CCCCHHHHHHHHHHH
11.8421082442
39PhosphorylationRSRKESYSVYVYKVL
CCCHHHHHHHHHHHH
19.0925159151
41PhosphorylationRKESYSVYVYKVLKQ
CHHHHHHHHHHHHHH
7.6627155012
41UbiquitinationRKESYSVYVYKVLKQ
CHHHHHHHHHHHHHH
7.6625015289
43PhosphorylationESYSVYVYKVLKQVH
HHHHHHHHHHHHHHC
4.2527273156
44AcetylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9238024255
44GlutarylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231542297
44LactoylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231645732
44MethylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.92-
44OtherSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9224681537
44UbiquitinationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9223000965
45UbiquitinationYSVYVYKVLKQVHPD
HHHHHHHHHHHHCCC
4.4025015289
47AcetylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9422631109
47GlutarylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9431542297
47MethylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9416627869
47OtherVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9424681537
47SumoylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9416627869
47UbiquitinationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9421906983
48UbiquitinationYVYKVLKQVHPDTGI
HHHHHHHHHCCCCCC
34.2925015289
53PhosphorylationLKQVHPDTGISSKAM
HHHHCCCCCCCHHHH
40.6530266825
53UbiquitinationLKQVHPDTGISSKAM
HHHHCCCCCCCHHHH
40.6523000965
55UbiquitinationQVHPDTGISSKAMGI
HHCCCCCCCHHHHHH
4.5723000965
56PhosphorylationVHPDTGISSKAMGIM
HCCCCCCCHHHHHHH
27.4223401153
57PhosphorylationHPDTGISSKAMGIMN
CCCCCCCHHHHHHHH
23.6330266825
58"N6,N6-dimethyllysine"PDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29-
58AcetylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29163971
58MethylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2916627869
58OtherPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2924681537
58UbiquitinationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2921906983
59UbiquitinationDTGISSKAMGIMNSF
CCCCCHHHHHHHHHH
11.9023000965
65PhosphorylationKAMGIMNSFVNDIFE
HHHHHHHHHHHHHHH
17.1222617229
68UbiquitinationGIMNSFVNDIFERIA
HHHHHHHHHHHHHHH
34.3523000965
71UbiquitinationNSFVNDIFERIAGEA
HHHHHHHHHHHHHHH
6.0223000965
73MethylationFVNDIFERIAGEASR
HHHHHHHHHHHHHHH
17.20-
79PhosphorylationERIAGEASRLAHYNK
HHHHHHHHHHHHHCC
24.4322617229
80MethylationRIAGEASRLAHYNKR
HHHHHHHHHHHHCCC
42.83-
82UbiquitinationAGEASRLAHYNKRST
HHHHHHHHHHCCCCC
11.2922817900
84PhosphorylationEASRLAHYNKRSTIT
HHHHHHHHCCCCCCC
19.4425884760
86"N6,N6,N6-trimethyllysine"SRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86AcetylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.337610065
86LactoylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3331645732
86MethylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86OtherSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3327105115
86UbiquitinationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3321906983
87MethylationRLAHYNKRSTITSRE
HHHHHCCCCCCCHHH
35.08-
88PhosphorylationLAHYNKRSTITSREI
HHHHCCCCCCCHHHH
26.2730266825
89PhosphorylationAHYNKRSTITSREIQ
HHHCCCCCCCHHHHH
32.1030266825
91PhosphorylationYNKRSTITSREIQTA
HCCCCCCCHHHHHHH
23.0930266825
92PhosphorylationNKRSTITSREIQTAV
CCCCCCCHHHHHHHH
24.8623401153
93MethylationKRSTITSREIQTAVR
CCCCCCHHHHHHHHH
36.07-
97PhosphorylationITSREIQTAVRLLLP
CCHHHHHHHHHHHCC
32.5523403867
100MethylationREIQTAVRLLLPGEL
HHHHHHHHHHCCHHH
19.70-
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.73-
109AcetylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7319608861
109GlutarylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7331542297
109LactoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7331645732
109MethylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7319608861
109NeddylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7332015554
109OtherLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7324681537
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7319608861
109UbiquitinationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHH
44.7327667366
110UbiquitinationLPGELAKHAVSEGTK
CCHHHHHHHHHHHHH
26.2527667366
113O-linked_GlycosylationELAKHAVSEGTKAVT
HHHHHHHHHHHHHHH
30.9622121020
113PhosphorylationELAKHAVSEGTKAVT
HHHHHHHHHHHHHHH
30.9628176443
116PhosphorylationKHAVSEGTKAVTKYT
HHHHHHHHHHHHHHC
16.2720068231
117SumoylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.28-
117AcetylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2819608861
117GlutarylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2831542297
117LactoylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2831645732
117MalonylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2822389435
117MethylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.28-
117NeddylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2832015554
117OtherHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2827105115
117SuccinylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2819608861
117SumoylationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2819608861
117UbiquitinationHAVSEGTKAVTKYTS
HHHHHHHHHHHHHCC
52.2823000965
120PhosphorylationSEGTKAVTKYTSSK-
HHHHHHHHHHCCCC-
24.1620068231
121SumoylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.67-
121AcetylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.67163829
121GlutarylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6731542297
121LactoylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6731645732
121MethylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.67-
121NeddylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6732015554
121OtherEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6727105115
121SuccinylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6719608861
121SumoylationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6719608861
121UbiquitinationEGTKAVTKYTSSK--
HHHHHHHHHCCCC--
39.6722389435
122PhosphorylationGTKAVTKYTSSK---
HHHHHHHHCCCC---
11.50-
123PhosphorylationTKAVTKYTSSK----
HHHHHHHCCCC----
28.2524719451
124PhosphorylationKAVTKYTSSK-----
HHHHHHCCCC-----
32.8027251275
126NeddylationVTKYTSSK-------
HHHHCCCC-------
65.2132015554
126UbiquitinationVTKYTSSK-------
HHHHCCCC-------
65.2123000965
133UbiquitinationK--------------
C--------------
23000965
141Ubiquitination----------------------
----------------------
23000965
145Ubiquitination--------------------------
--------------------------
23000965
150Ubiquitination-------------------------------
-------------------------------
23000965

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
15SPhosphorylationKinaseMST1P26927
Uniprot
15SPhosphorylationKinaseSTK4Q13043
GPS
15SPhosphorylationKinasePKA-FAMILY-GPS
15SPhosphorylationKinasePKA_GROUP-PhosphoELM
33SPhosphorylationKinasePKA-FAMILY-GPS
33SPhosphorylationKinasePKA_GROUP-PhosphoELM
37SPhosphorylationKinaseAMPKQ9Y478
Uniprot
37SPhosphorylationKinasePKA-FAMILY-GPS
37SPhosphorylationKinasePKA_GROUP-PhosphoELM
79SPhosphorylationKinaseAURKBQ96GD4
GPS
84YPhosphorylationKinaseAURKBQ96GD4
GPS
-KUbiquitinationE3 ubiquitin ligaseRNF20Q5VTR2
PMID:16307923
-KUbiquitinationE3 ubiquitin ligaseMSL2Q9HCI7
PMID:16627869

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
4KMethylation

16627869
4KMethylation

16627869
4Kubiquitylation

16627869
4Kubiquitylation

16627869
15SPhosphorylation

12757711
15SPhosphorylation

12757711
35KMethylation

21726816
35Kubiquitylation

21726816
37SPhosphorylation

12757711
79KMethylation

16627869
79KMethylation

16627869
79Kubiquitylation

16627869
79Kubiquitylation

16627869
113Subiquitylation

22121020
121Kubiquitylation

16627869
121Kubiquitylation

16627869
121KMethylation

16627869

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
17Acetylation27 (10)GS;R;Crs7766641
  • Height
28270201
17Crotonylation27 (10)GS;R;Crs7766641
  • Height
28270201
21Acetylation27 (6)GS;R;Crs7766641
  • Height
28270201
21Crotonylation27 (6)GS;R;Crs7766641
  • Height
28270201
24Acetylation27 (3)GS;R;Crs7766641
  • Height
28270201
24Crotonylation27 (3)GS;R;Crs7766641
  • Height
28270201
25Acetylation27 (2)GS;R;Crs7766641
  • Height
28270201
33Phosphorylation27 (6)GS;R;Crs7766641
  • Height
28270201
35Acetylation27 (8)GS;R;Crs7766641
  • Height
28270201
35Crotonylation27 (8)GS;R;Crs7766641
  • Height
28270201
35Ubiquitination27 (8)GS;R;Crs7766641
  • Height
28270201
37Phosphorylation27 (10)GS;R;Crs7766641
  • Height
28270201

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of H2B1C_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H2B1C_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-12; LYS-13; LYS-16;LYS-17; LYS-21; LYS-24 AND LYS-109, AND MASS SPECTROMETRY.
"Inhibition of core histones acetylation by carcinogenic nickel(II).";
Golebiowski F., Kasprzak K.S.;
Mol. Cell. Biochem. 279:133-139(2005).
Cited for: ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY.
"Characterization of histones H2A and H2B variants and their post-translational modifications by mass spectrometry.";
Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
Mol. Cell. Proteomics 5:541-552(2006).
Cited for: PROTEIN SEQUENCE OF 2-26, ACETYLATION AT LYS-13; LYS-16 AND LYS-21,AND MASS SPECTROMETRY.
Methylation
ReferencePubMed
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY.
O-linked Glycosylation
ReferencePubMed
"GlcNAcylation of histone H2B facilitates its monoubiquitination.";
Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S.,Imai Y., Kim J., He H.H., Igarashi K., Kanno J., Ohtake F.,Kitagawa H., Roeder R.G., Brown M., Kato S.;
Nature 480:557-560(2011).
Cited for: GLYCOSYLATION AT SER-113, AND UBIQUITINATION AT LYS-121.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND MASSSPECTROMETRY.
"Apoptotic phosphorylation of histone H2B is mediated by mammaliansterile twenty kinase.";
Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
Cell 113:507-517(2003).
Cited for: PHOSPHORYLATION AT SER-15.
Ubiquitylation
ReferencePubMed
"GlcNAcylation of histone H2B facilitates its monoubiquitination.";
Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S.,Imai Y., Kim J., He H.H., Igarashi K., Kanno J., Ohtake F.,Kitagawa H., Roeder R.G., Brown M., Kato S.;
Nature 480:557-560(2011).
Cited for: GLYCOSYLATION AT SER-113, AND UBIQUITINATION AT LYS-121.
"Histone H2B monoubiquitination functions cooperatively with FACT toregulate elongation by RNA polymerase II.";
Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A.,Reinberg D.;
Cell 125:703-717(2006).
Cited for: UBIQUITINATION AT LYS-121.
"Monoubiquitination of human histone H2B: the factors involved andtheir roles in HOX gene regulation.";
Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,Tempst P., Reinberg D.;
Mol. Cell 20:601-611(2005).
Cited for: UBIQUITINATION AT LYS-121.
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY.

TOP